CIK: 1640322 - Address: C/o Invitae Corporation, 1400 16Th Street, San Francisco, CA 94103
28 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111-502000-2
S%wins100100067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/15/23 16:58
6/13/23
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-101.380-7-1569D
5/18/23 16:18
5/16/23
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-321.200-26-4576D
3/15/23 16:23
3/13/23
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-41.410-3-1448D
8/18/22 16:22
8/16/22
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-324.550-7-2397D
5/19/22 17:26
5/17/22
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-233.810-6-1404D
3/16/22 20:52
3/14/22
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-1316.690-20-8241D
11/15/21 17:07
11/11/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS.d-65021.890-30-11246D
11/15/21 17:07
11/11/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d29910.0803014246D
8/20/21 19:05
1/3/17
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d21.2602New2D
8/18/21 19:38
8/16/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-54025.420-21-8246D
6/16/21 17:48
6/14/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-31331.630-10-4267D
3/19/21 17:11
3/15/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS.a-77942.900-18-7232D
3/17/21 21:35
3/12/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-77942.900-18-7232D
1/8/21 17:31
1/6/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d1009.900105225D
10/13/20 18:18
10/9/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d659.90073215D
9/14/20 18:43
9/10/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-77833.560-23-10209D
8/20/20 17:50
8/19/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-61132.100-19-8231D
7/13/20 17:21
7/9/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-1,01734.150-30-11250D
6/5/20 18:45
6/3/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d1989.9002010220D
5/22/20 18:42
5/20/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS.m-45817.130-27-12200D
3/16/20 21:40
3/16/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-12611.790-11-4227D
8/21/19 18:33
8/19/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-51725.290-20-12146D
5/22/19 19:58
5/20/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-13118.210-7-4167D
3/12/19 19:17
3/8/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeM.d999.900106174D
1/14/19 21:13
1/10/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-7314.010-5-3164D
1/14/19 21:09
11/12/18
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS.a-13713.110-10-6169D
5/16/18 21:06
5/15/18
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-476.960-7-1154D
2/15/17 20:22
2/15/17
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesNussbaum Robert LCAOChief MeS-169.532-2-361D-4551491211811-502

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact